Newsfiscal.ai
Callan JMB Announces Partnership with Rapid Dose Therapeutics for QuickStrip™ Manufacturing
· Published
Article summary
Callan JMB Inc. has entered into an agreement to install a production line for Rapid Dose Therapeutics' QuickStrip™ oral thin-film technology, projecting $15 million in revenue over the first 18 months.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…